We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
Fortive (FTV) to Boost Software Offerings Via Provation Buyout
Read MoreHide Full Article
Fortive Corporation (FTV - Free Report) has been consistently working toward expanding its portfolio of offerings on the back of strategic acquisitions.
FTV’s recent agreement with Clearlake Capital Group, L.P. for the acquisition of Provation Software validates the abovementioned fact. Fortive has agreed to pay $1.425 billion for the buyout.
Provation Software is a pioneer in providing clinical workflow software solutions that are utilized in hospitals and Ambulatory Surgical Centers.
In addition, the company offers innovative and advanced solutions for enhancing clinical productivity and care coordination. It also ensures accuracy in reporting and billing to sustain high-quality patient care.
We note that the buyout will strengthen Fortive’s capabilities in software development. Further, it will add strength to the company’s Advanced Sterilization Products and Censis, which in turn will bolster the Advanced Healthcare Solutions segment.
The acquisition is anticipated to be completed by year-end.
With the acquisition of Provation Software, Fortive will position itself well to penetrate the booming clinical workflow solutions market.
The market is witnessing significant growth due to the growing adoption of solutions based on healthcare information technology (HCIT) and electronic health record (EHR).
Also, growing initiatives by the government to support the increasing demand for HCIT and HER solutions is an added positive. The increasing number of patients infected by coronavirus is further propelling the market.
According to a report by Markets and Markets, the global clinical workflow solutions market is expected to hit $18.2 billion by 2025, registering a CAGR of 14.8% between 2020 and 2025.
Further, the market is likely to progress at a CAGR of 11.6% during the 2021-2026 period, per a report by Mordor Intelligence.
Bottom Line
The recent move bodes well for Fortive’s growing efforts toward bolstering its portfolio of services. The company’s strategic acquisitions have been acting as key catalysts in shaping up its growth trajectory.
Apart from the latest move, FTV recently acquired ServiceChannel and boosted the SaaS portfolio. It also acquired TeamSense and added innovative workflow solutions to the portfolio. Both the acquisitions have bolstered the Intelligent Operating Solutions segment.
Further, the Precision Technologies segment has been continuously benefiting from the strength of its subsidiary, Tektronix. Growing demand across Tektronix’s portfolio offerings remains a positive. Further, Tektronix recently introduced the S530 Parametric Test System with KTE V7.1 Software for speeding up the semiconductor chip production process, which is worth mentioning.
Image: Bigstock
Fortive (FTV) to Boost Software Offerings Via Provation Buyout
Fortive Corporation (FTV - Free Report) has been consistently working toward expanding its portfolio of offerings on the back of strategic acquisitions.
FTV’s recent agreement with Clearlake Capital Group, L.P. for the acquisition of Provation Software validates the abovementioned fact. Fortive has agreed to pay $1.425 billion for the buyout.
Provation Software is a pioneer in providing clinical workflow software solutions that are utilized in hospitals and Ambulatory Surgical Centers.
In addition, the company offers innovative and advanced solutions for enhancing clinical productivity and care coordination. It also ensures accuracy in reporting and billing to sustain high-quality patient care.
We note that the buyout will strengthen Fortive’s capabilities in software development. Further, it will add strength to the company’s Advanced Sterilization Products and Censis, which in turn will bolster the Advanced Healthcare Solutions segment.
The acquisition is anticipated to be completed by year-end.
Fortive Corporation Price and Consensus
Fortive Corporation price-consensus-chart | Fortive Corporation Quote
Prospects to Aid Fortive
With the acquisition of Provation Software, Fortive will position itself well to penetrate the booming clinical workflow solutions market.
The market is witnessing significant growth due to the growing adoption of solutions based on healthcare information technology (HCIT) and electronic health record (EHR).
Also, growing initiatives by the government to support the increasing demand for HCIT and HER solutions is an added positive. The increasing number of patients infected by coronavirus is further propelling the market.
According to a report by Markets and Markets, the global clinical workflow solutions market is expected to hit $18.2 billion by 2025, registering a CAGR of 14.8% between 2020 and 2025.
Further, the market is likely to progress at a CAGR of 11.6% during the 2021-2026 period, per a report by Mordor Intelligence.
Bottom Line
The recent move bodes well for Fortive’s growing efforts toward bolstering its portfolio of services. The company’s strategic acquisitions have been acting as key catalysts in shaping up its growth trajectory.
Apart from the latest move, FTV recently acquired ServiceChannel and boosted the SaaS portfolio. It also acquired TeamSense and added innovative workflow solutions to the portfolio. Both the acquisitions have bolstered the Intelligent Operating Solutions segment.
Further, the Precision Technologies segment has been continuously benefiting from the strength of its subsidiary, Tektronix. Growing demand across Tektronix’s portfolio offerings remains a positive. Further, Tektronix recently introduced the S530 Parametric Test System with KTE V7.1 Software for speeding up the semiconductor chip production process, which is worth mentioning.
Zacks Rank & Stocks to Consider
Currently, Fortive has a Zacks Rank #3 (Hold).
Investors interested in the broader technology sector can consider stocks like Advanced Micro Devices (AMD - Free Report) , Mimecast Limited and TaskUs (TASK - Free Report) , each carrying a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
Advanced Micro Devices has gained 51.6% on a year-to-date basis. The long-term earnings growth rate for the stock is currently projected at 46.2%.
Mimecast has gained 31.9% on a year-to-date basis. The long-term earnings growth rate for the stock is currently projected at 35%.
TaskUs has gained 25.7% on a year-to-date basis. The long-term earnings growth rate for the stock is currently projected at 32.8%.